Veranstaltungsdetail

III: Normal to pathological aging and LOE – Part 2 Clinical point of view; Challenges in neuropsychology ; Round Table Discussion III: Speakers and Coparticipants: Caveats for science and patients care, recommendations, tasks for the future; IV: Neurological comorbidities Neurodegenerative disorders; Aging with encephalopathies: extra long-term follow-up; Round Table Discussion IV: Speakers and Coparticipants: Caveats for science and patients care, recommendations, tasks for the future break V: New diagnostic approaches Structural and functional imaging as biomarkers; Seizures: age-specific semiology, detection and prediction; Round Table Discussion V: Speakers and Coparticipants: Caveats for science and patients care, recommendations, tasks for the future break VI: Old and new therapeutic approaches LOE–seizure risk, etiologies and indication for ASM; Age-dependency in ASM – real world data; Age-dependency in vagal nerve stimulation ; Adherence or compliance: the age-related characteristics; Round Table Discussion VI: Speakers and Coparticipants: Caveats for science and patients care, recommendations, tasks for the future. VII: Summarizing Joint Session and Closing remarks Caveats for science and patients care, recommendations, tasks for the future from the conference participants, also in view of ALOE_2028